Portfolio company
BONE THERAPEUTICS
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops allogeneic cell therapy products for patients suffering from orthopaedic conditions and bone diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Novadip Biosciences
This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
Novadip
This company develops regenerative tissue products to treat large bone defects and spinal fusion for patients with limited treatment options.
BIONCaRT
The company develops stem cell therapies for knee cartilage regeneration to treat patients with orthopaedic diseases.
Aurealis Pharma
This company develops cell and gene therapies for patients suffering from chronic wounds, cancer and inflammatory diseases.
Locate Bio
This company develops orthobiologic bone graft substitutes and regenerative medicine products for orthopaedic surgeons and healthcare providers treating musculoskeletal conditions.
Bonesupport
This company develops and manufactures injectable bioceramic bone graft substitutes for surgeons and healthcare providers to treat bone voids, defects and infections.
CynosBio
This company develops regenerative medicine products, including autologous cell therapies for ophthalmology and orthopaedics, serving healthcare professionals and patients with severe unmet medical needs.